CASALE, Maddalena
 Distribuzione geografica
Continente #
EU - Europa 5.281
NA - Nord America 2.323
AS - Asia 2.186
SA - Sud America 398
AF - Africa 37
OC - Oceania 1
Totale 10.226
Nazione #
RU - Federazione Russa 3.611
US - Stati Uniti d'America 2.272
SG - Singapore 860
CN - Cina 509
IE - Irlanda 506
IT - Italia 484
BR - Brasile 332
HK - Hong Kong 286
VN - Vietnam 230
DE - Germania 166
GB - Regno Unito 166
KR - Corea 98
UA - Ucraina 95
IN - India 54
GR - Grecia 46
FR - Francia 40
JP - Giappone 38
SE - Svezia 34
FI - Finlandia 33
AR - Argentina 30
AT - Austria 26
TR - Turchia 23
CA - Canada 22
MX - Messico 20
NL - Olanda 19
PK - Pakistan 17
BE - Belgio 13
IQ - Iraq 12
ZA - Sudafrica 11
BD - Bangladesh 10
CO - Colombia 9
ID - Indonesia 9
CH - Svizzera 8
DZ - Algeria 7
PY - Paraguay 7
UZ - Uzbekistan 7
CL - Cile 6
EC - Ecuador 6
VE - Venezuela 6
ES - Italia 5
JO - Giordania 5
KE - Kenya 5
CZ - Repubblica Ceca 4
LB - Libano 4
PL - Polonia 4
PT - Portogallo 4
TN - Tunisia 4
EG - Egitto 3
IR - Iran 3
KZ - Kazakistan 3
MA - Marocco 3
RS - Serbia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CY - Cipro 2
DO - Repubblica Dominicana 2
LT - Lituania 2
MK - Macedonia 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
TW - Taiwan 1
Totale 10.226
Città #
Moscow 1.301
Dublin 492
Singapore 406
Santa Clara 306
San Jose 301
Hong Kong 283
Chandler 231
Jacksonville 191
Ashburn 129
Seoul 97
Beijing 96
Ann Arbor 88
Ho Chi Minh City 81
Hefei 71
Bremen 70
Princeton 70
Caserta 69
Roxbury 66
Naples 61
Hanoi 53
Dallas 52
Medford 52
New York 46
Bengaluru 37
The Dalles 37
Woodbridge 35
São Paulo 34
Munich 28
Nanjing 25
Wilmington 25
Des Moines 23
Ercolano 23
Rome 22
Boardman 21
Cambridge 19
Los Angeles 19
Da Nang 18
Grumo Nevano 17
Vienna 17
Napoli 16
Council Bluffs 15
Brussels 13
Haiphong 13
Helsinki 13
Nuremberg 12
Milan 10
Pescara 10
Atlanta 9
Belo Horizonte 9
Falkenstein 9
San Mateo 9
Boston 8
Curitiba 8
Johannesburg 8
Pozzuoli 8
Amsterdam 7
Brasília 7
Brooklyn 7
Mexico City 7
Nanchang 7
Nocera Inferiore 7
Redwood City 7
Rio de Janeiro 7
Tashkent 7
Aversa 6
Chicago 6
Fairfield 6
Hải Dương 6
Istanbul 6
London 6
Montreal 6
Mountain View 6
Orem 6
Orlando 6
Seattle 6
Shanghai 6
Shenyang 6
Tianjin 6
Turku 6
Asunción 5
Biên Hòa 5
Campinas 5
Chennai 5
Elora 5
Houston 5
Kunming 5
Nairobi 5
Salvador 5
San Sebastiano al Vesuvio 5
Stella Cilento 5
Toronto 5
Amman 4
Auburn Hills 4
Brno 4
Buenos Aires 4
Changchun 4
Fortaleza 4
Frankfurt am Main 4
Guangzhou 4
Hillsboro 4
Totale 5.431
Nome #
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 219
Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia 213
Blood transfusions and adverse acute events: a retrospective study from 214 transfusion-dependent pediatric patients comparing transfused blood components by apheresis or by whole blood 196
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. 185
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. 181
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 174
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 171
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation) 167
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 167
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 157
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 157
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 152
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature 148
Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned 147
Congenital Dyserythropoietic Anemia Type II: molecular analysis and expression of the SEC23B Gene. 145
BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX 145
Cb2 receptor stimulation and dexamethasone restore the anti-inflammatory and immune-regulatory properties of mesenchymal stromal cells of children with immune thrombocytopenia 145
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 141
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance study 141
Association of immune thrombocytopenia and celiac disease in children: A retrospective case control study 139
[The Management of Endocrine Complications in Patients with Haemoglobinopathies: Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE).] 138
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 138
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 137
An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective 137
National systematic approach to the management of asplenia: the set up of the Italian Network on Asplenia 131
Access to emergency department for acute events and identification of sickle cell disease in refugees. 129
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients 125
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 125
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 125
Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients 124
Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study 119
Clinical and molecular spectrum of glucose-6-phosphate isomerase deficiency. Report of 12 new cases 119
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 113
Rubrica a cura di luciano de seta quando il saturimetro mente… 109
Response to measles, mumps and rubella (Mmr) vaccine in transfusion-dependent patients 109
Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major 108
CB2 and TRPV1 receptors in inflammatory state of macrophages from sickle cell anemia pediatric/young adults 106
Management of the risk for severe infections in children with asplenia: Recommendations from the Italian Network of Asplenia 105
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 105
Deferasirox: la chelazione ottimale nelle anemie trasfusione-dipendenti 104
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. 104
Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis 103
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 102
Organizing national responses for rare blood disorders: The Italian experience with sickle cell disease in childhood 101
Splenectomy for hereditary spherocytosis: complete, partial or not at all? 101
Longitudinal Prospective MRI Study in Pediatric Patients With Thalassemia Major 101
Life-Threatening Drug-Induced Liver Injury in a Patient with β-Thalassemia Major and Severe Iron Overload on Polypharmacy. 101
Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: Analysis of 78 patients from 21 families 99
Hb Vanvitelli: A new unstable α-globin chain variant causes undiagnosed chronic haemolytic anaemia when co-inherited with deletion − α3.7. 99
Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national database 98
Acute chest syndrome in children with sickle cell disease: Data from a national AIEOP cohort identify priority areas of intervention in a hub-and-spoke system 98
Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia 97
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 96
Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene 95
Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey. 94
Screening for sickle cell disease by point-of-care tests in Italy: pilot study on 1000 at risk children 93
Prospective MRI study in pediatric thalassemia major (TM) patients in the MIOT network: a tool to strengthen medical decisions 93
Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP) 92
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology 91
Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study 90
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 90
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm 90
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 88
Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study 87
Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up 87
Nineteen-month-old girl with persistent fever 87
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 87
Reply to "Hepatocellular carcinoma in thalassemia and other hemoglobinopathies" 86
HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype-phenotype correlation 86
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy 86
Myocardial fibrosis by CMR LGE in a large cohort of pediatric thalassemia major patients 85
Red blood cell alloimmunisation in transfusion-dependent thalassaemia: A systematic review 85
Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority 85
Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with Haemoglobinopathies 85
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021 84
Thyroid Nodule Surveillance in Transfusion-Dependent Thalassemia: A Comparative Ultrasonographic Study 83
Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network 83
Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study 82
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters 81
Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia 81
Early splenectomy in sickle cell disease: another piece of the puzzle 80
Thalassemia-Associated mixed hypogonadism (TAMH): unraveling a unique endocrine pattern and its impact on cardiovascular risk 79
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 79
Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose 77
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 75
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major 74
Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey 69
Impairment of Innate Immunity and Depletion of Vaccine‐Induced Memory B and T Cells in the Absence of the Spleen 69
Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values 68
Will the changing therapeutic landscape meet the needs of patients with sickle cell disease? 68
Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients 66
Thalassemias and Sickle Cell Diseases in Pregnancy: SITE Good Practice 53
GROWTH ABNORMALITIES, ENDOCRINE, AND BONE DISEASE 45
FERTILITY AND PREGNANCY. In: Taher AT, Farmakis D, Porter JB, Cappellini MD, Musallam KM, eds. Guidelines for the Management of Transfusion-Dependent β-Thalassaemia (TDT). 5th ed. Nicosia, Cyprus: Thalassaemia International Federation; 2025. 44
The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape 40
Oxford Hip and Shoulder Scores as Potential Tools for the Early Detection of Avascular Necrosis in Apparently Unaffected Sites in Sickle Cell Disease: Results from a Prospective Cohort Study 38
Incorporating national disease burden in GBD estimates of haemoglobinopathies in Italy 26
Corrigendum to "Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study" [Diab. Res. Clin. Pract. 222 (2025) 112076] 21
null 16
Oxford Hip and Shoulder Scores as Potential Tools for the Early Detection of Avascular Necrosis in Apparently Unaffected Sites in Sickle Cell Disease: Results from a Prospective Cohort Study 7
Totale 10.446
Categoria #
all - tutte 36.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022465 14 0 7 9 125 31 40 21 23 21 35 139
2022/2023974 103 26 28 60 129 77 0 52 454 10 19 16
2023/2024356 30 14 14 18 132 39 2 10 4 3 28 62
2024/20251.432 10 10 10 44 212 163 244 170 223 110 129 107
2025/20266.141 234 283 332 303 556 3.327 272 269 237 184 104 40
Totale 10.450